Andra AP-fonden’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,800
| Closed | -$552K | – | 404 |
|
|
2024
Q3 | $552K | Sell |
2,800
-8,100
| -74% | -$1.6M | 0.01% | 390 |
|
|
2024
Q2 | $2.25M | Sell |
10,900
-300
| -3% | -$62K | 0.04% | 347 |
|
|
2024
Q1 | $3.03M | Buy |
+11,200
| New | +$3.03M | 0.05% | 312 |
|
|
2023
Q3 | – | Sell |
-8,100
| Closed | -$1.7M | – | 333 |
|
|
2023
Q2 | $1.7M | Buy |
8,100
+5,800
| +252% | +$1.22M | 0.04% | 542 |
|
|
2023
Q1 | $464K | Buy |
+2,300
| New | +$464K | 0.01% | 550 |
|
|
2022
Q3 | – | Sell |
-9,500
| Closed | -$2.03M | – | 562 |
|
|
2022
Q2 | $2.03M | Buy |
+9,500
| New | +$2.03M | 0.06% | 504 |
|
|
2021
Q4 | $1.77M | Sell |
4,700
-2,300
| -33% | -$867K | 0.04% | 514 |
|
|
2021
Q3 | $2.89M | Buy |
7,000
+1,400
| +25% | +$578K | 0.06% | 525 |
|
|
2021
Q2 | $2.07M | Buy |
+5,600
| New | +$2.07M | 0.04% | 557 |
|